North America Ophthalmology Drugs and Devices Market 2019-2027

Market Outlook

According to the author, the North American ophthalmology drugs and devices market is estimated to flourish with a CAGR of 6.10% in the forecasting years 2019-2027. The countries of the United States and Canada together form the market for ophthalmology drugs and devices in the North American region. The Canada ophthalmology drugs and devices market is primarily driven by various grants and funding to support ophthalmology research and the high prevalence of diabetes in the country. According to the Dalhousie University (Canada), in 2016, the Department of Ophthalmology and Visual Sciences invested funds of around $4.6 million in assessing and developing new diagnostic tools and devices to allow ophthalmologists to offer the best care by detecting the disease accurately. This funding was aimed to support various researches in ophthalmology, with a goal of inventing new & advanced drugs and devices, which is expected to boost the growth of the ophthalmology drug and devices market in Canada. Furthermore, the high prevalence of diabetes in Canada also drives the ophthalmology drugs and devices market in the country, as the disease is a leading cause of vision loss. According to the Canadian Diabetes Association, in 2016, around 3.5 million people in the country were living with diabetes, and the number is further expected to reach around 4.9 million by 2026. Hence, the rising prevalence of diabetes positively influences the growth of the ophthalmology drugs and devices market in Canada during the forecast period.

Competitive Outlook
Few of the prime players in this market are GlaxoSmithKline, Johnson & Johnson, Inc., Novartis International AG, Pfizer, Roche Holding AG and Santen Pharmaceutical Co., Ltd.

1. North America Ophthalmology Drugs and Devices Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Force Analysis
2.2.1. Bargaining Power of Buyers
2.2.2. Bargaining Power of Supplier
2.2.3. Threats of New Entrants
2.2.4. Threats of Substitutes
2.2.5. Competitive Rivalry
2.3. Strategic Outlook
2.4. Key Insight
2.5. Value Chain Outlook
2.6. Key Buying Standards
2.7. Supply Chain Outlook
2.8. Regulatory Framework
2.9. Market Drivers
2.9.1. Increasing Ophthalmic Disorders Due to High Blood Sugar
2.9.2. Upsurge in Healthcare Spending
2.9.3. Technological Advancement
2.10. Market Restraints
2.10.1. Expirations of Brand Patents Have Affected the Pharmaceutical Industry
2.10.2. Low Cognizance Related to Ophthalmic Drugs
2.10.3. Drug Approvals Delay and Number of Drugs in the Pipeline
2.11. Market Opportunities
2.11.1. Demand for Phacoemulsification Devices and Intraocular Lenses Is Increasing
2.12. Market Challenges
2.12.1. Difficulties Associated With the Conduct of Ocular Diseases

3. Ophthalmology Drugs and Devices Market Outlook - by Drugs and Devices
3.1. Devices
3.1.1. Diagnostic & Monitoring Equipment
3.1.1.1. Optical Coherence Tomography
3.1.1.2. Ophthalmic Ultrasound Imaging Systems
3.1.1.3. Fundus Camera Market
3.1.1.4. Ophthalmoscopes
3.1.1.5. Retinoscope
3.1.1.6. Pachymeter
3.1.1.7. Wavefront Aberrometers
3.1.1.8. Perimeters/Visual Field Analyzer
3.1.1.9. Autorefractors/Phoropter
3.1.1.10. Specular Microscope
3.1.1.11. Corneal Topographers
3.1.1.12. Other Diagnostic & Monitoring Equipment Market
3.1.2. Surgery Devices
3.1.2.1. Cataract Surgery Devices
3.1.2.2. Glaucoma Surgery Devices
3.1.2.3. Refractive Surgery Devices
3.1.2.4. Vitreoretinal Surgery Devices
3.1.3. Vision Care
3.2. Drugs
3.2.1. Glaucoma Drug
3.2.2. Retinal Disorder Drug
3.2.3. Dry Eye Drug
3.2.4. Allergic Conjunctivitis, Inflammation and Conjunctivitis Drug
3.2.5. Drugs by Use of Preservation
3.2.5.1. Preserved Drugs
3.2.5.2. Preservative-Free Drugs

4. Ophthalmology Drugs and Devices Market - Regional Outlook
4.1. The United States
4.2. Canada

5. Competitive Landscape
5.1. Allergan, Inc.
5.2. Bayer
5.3. Carl Zeiss AG
5.4. Essilor International S.A.
5.5. Glaxosmithkline
5.6. Johnson & Johnson, Inc.
5.7. Novartis International AG
5.8. Pfizer
5.9. Roche Holding AG
5.10. Santen Pharmaceutical Co., Ltd.

6. Methodology and Scope
6.1. Research Scope
6.2. Sources of Data
6.3. Research MethodologyList of Tables
Table 1 North America Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Table 2 Common Causes of Loss of Vision in the Elderly
Table 3 Selected List of Glaucoma Drugs in Late-Stage Clinical Trials
Table 4 North America Ophthalmology Drugs and Devices Market by Drugs and Devices 2019-2027 ($ Million)
Table 5 North America Devices Market in Diagnostic & Monitoring Equipment by Types 2019-2027 ($ Million)
Table 6 North America Devices Market in Surgery Device by Types 2019-2027 ($ Million)
Table 7 North America Drugs and Devices Market in Drugs by Types 2019-2027 ($ Million)
Table 8 North America Ophthalmology Drugs and Devices Market by Countries 2019-2027 ($ Million)

List of Figures
Figure 1 North America Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 2 North America Drugs and Devices Market in Devices 2019-2027 ($ Million)
Figure 3 North America Devices Market in Diagnostic & Monitoring Equipment 2019-2027 ($ Million)
Figure 4 North America Diagnostic & Monitoring Equipment Market in Optical Coherence Tomography 2019-2027 ($ Million)
Figure 5 North America Diagnostic & Monitoring Equipment Market in Ophthalmic Ultrasound Imaging Systems 2019-2027 ($ Million)
Figure 6 North America Diagnostic & Monitoring Equipment Market in Fundus Camera Market 2019-2027 ($ Million)
Figure 7 North America Diagnostic & Monitoring Equipment Market in Ophthalmoscopes 2019-2027 ($ Million)
Figure 8 North America Diagnostic & Monitoring Equipment Market in Retinoscope 2019-2027 ($ Million)
Figure 9 North America Diagnostic & Monitoring Equipment Market in Pachymeter 2019-2027 ($ Million)
Figure 10 North America Diagnostic & Monitoring Equipment Market in Wavefront Aberrometers 2019-2027 ($ Million)
Figure 11 North America Diagnostic & Monitoring Equipment Market in Perimeters/Visual Field Analyzer 2019-2027 ($ Million)
Figure 12 North America Diagnostic & Monitoring Equipment Market in Autorefractors/Phoropter 2019-2027 ($ Million)
Figure 13 North America Diagnostic & Monitoring Equipment Market in Specular Microscope 2019-2027 ($ Million)
Figure 14 North America Diagnostic & Monitoring Equipment Market in Corneal Topographers 2019-2027 ($ Million)
Figure 15 North America Diagnostic & Monitoring Equipment Market in Other Diagnostic & Monitoring Equipment Market 2019-2027 ($ Million)
Figure 16 North America Devices Market in Surgery Device 2019-2027 ($ Million)
Figure 17 North America Surgery Devices Market in Cataract Surgery Devices 2019-2027 ($ Million)
Figure 18 North America Surgery Devices Market in Glaucoma Surgery Devices 2019-2027 ($ Million)
Figure 19 North America Surgery Devices Market in Refractive Surgery Devices 2019-2027 ($ Million)
Figure 20 North America Surgery Devices Market in Vitreoretinal Surgery Devices 2019-2027 ($ Million)
Figure 21 North America Devices Market in Vision Care Market 2019-2027 ($ Million)
Figure 22 North America Drugs and Devices Market in Drugs 2019-2027 ($ Million)
Figure 23 North America Drugs Market in Glaucoma Drug 2019-2027 ($ Million)
Figure 24 North America Drugs Market in Retinal Disorder Drug 2019-2027 ($ Million)
Figure 25 North America Drugs Market in Dry Eye Drug 2019-2027 ($ Million)
Figure 26 North America Drugs Market in Allergic Conjunctivitis, Inflammation and Conjunctivitis Drug 2019-2027 ($ Million)
Figure 27 North America Drugs by Use of Preservation in Preserved Drugs 2019-2027 ($ Million)
Figure 28 North America Drugs by Use of Preservation in Preservative-Free Drugs 2019-2027 ($ Million)
Figure 29 North America Preservative-Free Drugs Market in Single-Dose 2019-2027 ($ Million)
Figure 30 North America Preservative-Free Drugs Market in Multi-Dose 2019-2027 ($ Million)
Figure 31 The United States Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 32 Canada Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)